Tang Lab

Laboratory of Biomaterials for Immunoengineering

EPFL spin-off develops protein to boost immunotherapy

See more

EPFL spin-off Leman Biotech has developed a protein that can improve the effectiveness of immunotherapy drugs used to treat some types of cancer. The firm has just completed its first funding round, in the amount of $11 million.

Postdoctoral position opening

See more

One full-time postdoctoral position in cancer immunotherapy and immunoengineering projects is immediately available in Tang lab at Swiss Federal Institute of Technology in Lausanne (EPFL).

Our research

Our immune system is constantly defending us from many diseases through profound interactions with invaders or diseased cells. Such interactions are multi-dimensional involving substantial biological, chemical, and physical exchanges. The overarching goal of Tang laboratory is to develop novel strategies to engineer the multi-dimensional immunity-disease interactions, an emerging field called ‘immunoengineering’, to create safe and effective therapies against cancer and infectious diseases. We leverage the power of metabolic and cellular bioengineering, synthetic chemistry and material engineering, and mechanical engineering to achieve controllable modulation of immune responses. There are three interconnected themes in our research program:

1) to reprogram immune cell metabolism with engineered proteins, cells, and molecules for enhanced proliferation, function, and longevity (Metabolic immunoengineering)

2) to achieve tissue-/cell-specific immune modulation using responsive chemistry and smart biomaterials (Chemical immunoengineering)

3) to manipulate the mechanical properties and interactions at cellular and tissue levels for enhanced immunotherapy (Mechanical immunoengineering)


Head of Laboratory : Li Tang
MED 1 2826, Station 9
CH-1015 Lausanne, Switzerland
Phone : +41 21 693 0937
Email: [email protected]

Administrative Assistant : Monica Navarro Suarez
MED 1 2726, Station 9
CH-1015 Lausanne, Switzerland
Phone : +41 21 693 0756
Email: [email protected]

Access map